Review



nkg2a polyclonal antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Bioss nkg2a polyclonal antibody
    Nkg2a Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nkg2a polyclonal antibody/product/Bioss
    Average 92 stars, based on 5 article reviews
    nkg2a polyclonal antibody - by Bioz Stars, 2026-02
    92/100 stars

    Images



    Similar Products

    92
    Bioss nkg2a polyclonal antibody
    Nkg2a Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nkg2a polyclonal antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    nkg2a polyclonal antibody - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    92
    Bioss anti nkg2a antibody
    Alignment of the <t>NKG2A</t> VHH sequence with the reference sequence from GenBank. The complementarity-determining region 3 (CDR3) motif is highlighted with yellow boxes.
    Anti Nkg2a Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti nkg2a antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    anti nkg2a antibody - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    92
    Bioss rabbit anti nkg2a
    Alignment of the <t>NKG2A</t> VHH sequence with the reference sequence from GenBank. The complementarity-determining region 3 (CDR3) motif is highlighted with yellow boxes.
    Rabbit Anti Nkg2a, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti nkg2a/product/Bioss
    Average 92 stars, based on 1 article reviews
    rabbit anti nkg2a - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    nkg2a  (Bioss)
    92
    Bioss nkg2a
    Alignment of the <t>NKG2A</t> VHH sequence with the reference sequence from GenBank. The complementarity-determining region 3 (CDR3) motif is highlighted with yellow boxes.
    Nkg2a, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nkg2a/product/Bioss
    Average 92 stars, based on 1 article reviews
    nkg2a - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    Image Search Results


    Alignment of the NKG2A VHH sequence with the reference sequence from GenBank. The complementarity-determining region 3 (CDR3) motif is highlighted with yellow boxes.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: Alignment of the NKG2A VHH sequence with the reference sequence from GenBank. The complementarity-determining region 3 (CDR3) motif is highlighted with yellow boxes.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Sequencing

    Expression of VHH in NKG2A-VHH-A3-1 at varying concentrations of IPTG, as analyzed by western blotting.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: Expression of VHH in NKG2A-VHH-A3-1 at varying concentrations of IPTG, as analyzed by western blotting.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Expressing, Western Blot

    Expression levels of VHH in NKG2A-VHH-A3-1 at various IPTG concentrations, assessed by Coomassie Blue staining.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: Expression levels of VHH in NKG2A-VHH-A3-1 at various IPTG concentrations, assessed by Coomassie Blue staining.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Expressing, Staining

    (A) SDS-PAGE (heated CBB staining) results and (B) Western blotting results showed the results of NKG2A VHH affinity chromatography.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: (A) SDS-PAGE (heated CBB staining) results and (B) Western blotting results showed the results of NKG2A VHH affinity chromatography.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: SDS Page, Staining, Western Blot, Affinity Chromatography

    The affinity between NKG2A VHH and the antigen was detected using indirect ELISA. An anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS acted as a negative control instead of the NKG2A polypeptide antigen. BSA was used as a blank control. Three replicates were established for each group. *** p < 0.001.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: The affinity between NKG2A VHH and the antigen was detected using indirect ELISA. An anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS acted as a negative control instead of the NKG2A polypeptide antigen. BSA was used as a blank control. Three replicates were established for each group. *** p < 0.001.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Indirect ELISA, Positive Control, Negative Control, Control

    NKG2A VHH was used to assess the distribution of NKG2A in tissues. PBS served as a negative control. The NKG2A VHH is located in NK cells in the red pulp region of spleen tissue. Red arrows indicate the red pulp region, while the black arrow represents the zoom.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: NKG2A VHH was used to assess the distribution of NKG2A in tissues. PBS served as a negative control. The NKG2A VHH is located in NK cells in the red pulp region of spleen tissue. Red arrows indicate the red pulp region, while the black arrow represents the zoom.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Negative Control

    The effect of NKG2A VHH nanobody at different doses on melanoma growth in the Balb/c mouse model. (A) Schematic diagram of NKG2A VHH for the treatment of malignant melanoma in mice. (B) Compared to the PBS control group, the 30 μg dose had a minimal effect, the 50 μg dose showed a noticeable effect, and the 70 μg dose demonstrated a significant effect. (C) Tumor weights in the control group were compared to the experimental group after drug treatment. *** p < 0.001. (D) Growth rates of allogeneic tumors in Balb/c mice at various doses during tumor volume assays from 0 to 30 days.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: The effect of NKG2A VHH nanobody at different doses on melanoma growth in the Balb/c mouse model. (A) Schematic diagram of NKG2A VHH for the treatment of malignant melanoma in mice. (B) Compared to the PBS control group, the 30 μg dose had a minimal effect, the 50 μg dose showed a noticeable effect, and the 70 μg dose demonstrated a significant effect. (C) Tumor weights in the control group were compared to the experimental group after drug treatment. *** p < 0.001. (D) Growth rates of allogeneic tumors in Balb/c mice at various doses during tumor volume assays from 0 to 30 days.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: Control

    Model for the preparation of novel nanoantibody drugs for NKG2A VHH and treatment for MM.

    Journal: Frontiers in Veterinary Science

    Article Title: A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

    doi: 10.3389/fvets.2025.1571857

    Figure Lengend Snippet: Model for the preparation of novel nanoantibody drugs for NKG2A VHH and treatment for MM.

    Article Snippet: Anti-NKG2A antibody (Bioss, bs-2411R) served as a positive control, while PBS was used as a negative control instead of the NKG2A polypeptide antigen.

    Techniques: